# MIDOSTAURIN
> **ANDA216076** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS · Approved 2024-04-29
## Drug
- **FDA Application Number:** ANDA216076
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MIDOSTAURIN
- **Generic name:** Midostaurin
- **Active ingredients:** MIDOSTAURIN
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** TEVA PHARMS
- **First approval:** 2024-04-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216076)
---
*AI Analytics · CC0 1.0*